Opportunity Information: Apply for 72048225RFA00002

The Strengthening Malaria Control for High-Risk Communities opportunity is a USAID Thailand (Bangkok) discretionary funding announcement issued as a Request for Applications (RFA) under Funding Opportunity Number 72048225RFA00002. It is structured as a cooperative agreement, which typically means the recipient will carry out program activities with substantial involvement from USAID during implementation (for example, collaboration on technical approaches, work planning, monitoring, and coordination). The funding activity category is Health, and it is listed under CFDA 98.001.

The notice provided is specifically an Amendment No. 1 to the original RFA. The amendment’s purpose is narrow and administrative: it addresses and responds to questions that were submitted by the stated question deadline. The amendment does not change the rest of the solicitation requirements, meaning that the original terms, conditions, expectations, and application instructions from the October 25, 2024 issuance remain in effect unless applicants see explicit changes in the amendment documentation itself.

Key dates anchor the application process. The RFA issuance date is October 25, 2024. Questions were due by November 6, 2024 at 9:00 a.m. Bangkok time, and applications are due by December 6, 2024 at 9:00 a.m. Bangkok time. From a practical standpoint, applicants should treat the Q and A content included in the amendment as part of the solicitation package, since USAID responses to questions often clarify how USAID interprets requirements, what is considered responsive, and how certain technical or administrative elements should be handled.

In terms of scale and competitiveness, USAID anticipates making a single award (Expected Awards: 1) with an award ceiling of up to $15,000,000. That indicates a relatively large, centralized activity rather than multiple smaller grants. Eligible applicants are listed as “Unrestricted,” which generally signals that a wide range of entities may apply (such as nonprofits, for-profits, universities, and potentially other organizations), subject to standard USAID eligibility rules and any specific requirements stated in the full RFA package.

Although the excerpt does not include the technical program description beyond the title, the focus implied by “Strengthening Malaria Control for High-Risk Communities” is malaria prevention and control interventions targeted to populations at elevated risk. In Southeast Asia and similar contexts, “high-risk communities” commonly refers to groups with higher exposure due to geography, mobility, occupation, or limited access to routine services, and programs under this theme often emphasize improved case detection and treatment, surveillance and response, targeted vector control, community outreach and behavior change, and coordination with national malaria programs and local health systems. Applicants would need to rely on the full RFA document for the precise geographic scope, target populations, required results, and any mandated technical strategies.

Bottom line: this is a USAID Bangkok health opportunity for a single cooperative agreement award up to $15 million, with applications due December 6, 2024 (9:00 a.m. Bangkok time). The posted amendment does not change deadlines or major terms; it exists to publish USAID’s answers to applicant questions, and those clarifications should be read carefully alongside the original solicitation when preparing an application.

  • The Thailand USAID-Bangkok in the health sector is offering a public funding opportunity titled "Strengthening Malaria Control for High-Risk Communities" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001.
  • This funding opportunity was created on 2024-10-24.
  • Applicants must submit their applications by 2024-12-06. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $15,000,000.00 in funding.
  • The number of recipients for this funding is limited to 1 candidate(s).
  • Eligible applicants include: Unrestricted.
Apply for 72048225RFA00002

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: Thailand USAID-Bangkok

Browse more opportunities from the same category: Health

Next opportunity: BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)

Previous opportunity: SEMICONDUCTOR SUPPLY CHAIN AND CYBERSECURITY ASSESSMENT

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for 72048225RFA00002

 

Applicants also applied for:

Applicants who have applied for this opportunity (72048225RFA00002) also looked into and applied for these:

Funding Opportunity
Implementation Research for Multi-morbidity Management in the Context of Non-communicable Diseases in Low- and Middle-Income Countries and US Tribal Populations (R61/R33 Clinical Trial Required) Apply for PAR 25 223

Funding Number: PAR 25 223
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Development of Resources and Technologies for Enhancing Rigor, Reproducibility, and Translatability of Animal Models in Biomedical Research (R01 Clinical Trial Not Allowed) Apply for PAR 25 076

Funding Number: PAR 25 076
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards (U01 - Clinical Trials Required) Apply for PAR 25 149

Funding Number: PAR 25 149
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed) Apply for PAR 25 122

Funding Number: PAR 25 122
Agency: National Institutes of Health
Category: Health
Funding Amount: $100,000
Facilitating T1 Translational Aging Research: Preclinical and Early Phase Human Studies (UG3/UH3 Clinical Trial Optional) Apply for RFA AG 25 027

Funding Number: RFA AG 25 027
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional) Apply for PAR 25 024

Funding Number: PAR 25 024
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed) Apply for PAR 24 326

Funding Number: PAR 24 326
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed) Apply for PAR 24 265

Funding Number: PAR 24 265
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed) Apply for PAR 24 264

Funding Number: PAR 24 264
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Translational Neural Devices (R61/R33 - Clinical Trial Optional) Apply for PAR 25 053

Funding Number: PAR 25 053
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R21 Clinical Trial Optional) Apply for RFA MH 25 206

Funding Number: RFA MH 25 206
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R01 Clinical Trial Optional) Apply for RFA MH 25 205

Funding Number: RFA MH 25 205
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Required) Apply for PAR 24 313

Funding Number: PAR 24 313
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required) Apply for PAR 24 312

Funding Number: PAR 24 312
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required) Apply for PAR 25 207

Funding Number: PAR 25 207
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required) Apply for PAR 25 206

Funding Number: PAR 25 206
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed) Apply for PAR 25 077

Funding Number: PAR 25 077
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
NINDS Sustainable Transformation of Institutional Research Rigor (STIRR) Program (RC2 - Clinical Trial Not Allowed) Apply for RFA NS 25 019

Funding Number: RFA NS 25 019
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) Apply for PAR 25 225

Funding Number: PAR 25 225
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Combating Antibiotic-Resistant Bacteria Interdisciplinary Research Units (CARBIRUs) (P01 Clinical Trial Not Allowed) Apply for RFA AI 24 074

Funding Number: RFA AI 24 074
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,500,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "72048225RFA00002", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: